Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Active substance : clopidogrel
  • Active substance : morphine
  • Active substance : ivabradine
  • Active substance : potassium
  • Topics : Quality of care and patient safety
  • Topics : Myocardial ischemia
Filter
Topic
  • Diseases and conditions (1)
  • Plus ...
    • Heart diseases (1)
    • Plus ...
      • Myocardial ischemia (1)
  • Quality of care and patient safety (1)
  • Plus ...
    • Indicators (1)
Content type
  • Articles and news (1)
  • Plus ...
    • Web page (1)
Language
  • Français (1)
Active substance
  • alcool (1)
  • clopidogrel (1)
  • ivabradine (1)
  • morphine (1)
  • nicotine (1)
  • potassium (1)
  • prasugrel (1)

Articles and news - 1 result

  • Myocardial Infarction (MI) Full Care Cycle and Patient Outcomes

    Web page - Posted on 30/4/2013 - Mis à jour le 23/5/2013
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
Qmq9ALwFH0AJJmn5